Health Canada26 Jun 2026
Remifentanil hydrochloride for injection; Out of specification (Assay & Impurity)
Health Canada published a recall notice for Remifentanil hydrochloride for injection; Out of specification (Assay & Impurity) on 26 Jun 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 26 Jun 2026
- Recall type
- Health product recall
- Companies
- Sterimax Inc.2770 Portland DriveOakville Ontario L6H 6R4 Canada
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: The assay and impurity is out of specification in the affected lots. What you should do What to do: Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Number Sterimax Inc. Remifentanil hydrochloride for injection DIN 02366460 Powder for solution Remifentanil hydrochloride 1 mg/vial 243101O, 243110D, 253101D Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.